TRA16 was significantly upregulated in 13 cancer types, including adrenocortical carcinoma (ACC), cervical squamous cell carcinoma (CESC), colon adenocarcinoma (COAD), diffuse large B-cell lymphoma (DLBC), glioblastoma multiforme (GBM), kidney renal papillary cell carcinoma (KIRP), lower-grade glioma (LGG), liver hepatocellular carcinoma (LIHC), lung squamous cell carcinoma (LUSC), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), testicular germ cell tumors (TGCT), and thymoma (THYM). Here, NR2C2AP is linked to adrenal cortex carcinoma.